HomeNewsBusinessMarketsNifty hovers around 8450, Midcap outperforms; Dr Reddy's up

Nifty hovers around 8450, Midcap outperforms; Dr Reddy's up

Dr Reddy's Labs rallied 1.5 percent as the company launched its Memantine hydrochloride tablets (a generic version of Namenda) in the US while Sun Pharma slipped half a percent as sources told CNBC-TV18 that USFDA has audited company's API facility in Ahmednagar, Maharashtra.

July 14, 2015 / 11:15 IST
Story continues below Advertisement

Moneycontrol Bureau

At 10:58 am Market Update: The Sensex declined 20.01 points to 27941.18 and the Nifty dropped 8.55 points to 8451.10. About 1437 shares have advanced, 799 shares declined, and 117 shares are unchanged on the BSE.

Story continues below Advertisement

Sakhti Siva of Credit Suisse says the brokerage is now trimming from 1 percent overweight to a modest 1 percent underweight. "We emphasise that this is more of a tactical call based on valuations and we still believe India's return on equity is likely to rise in 2016," she reasoned.

Credit Suisse downgraded four mid-cap Indian stocks on valuations while their top picks from the CS regional portfolio are Axis Bank and HCL Technologies.